[1]
A. Dovach, K. Al Saad, and L. Haliem, “Study Design and Baseline Characteristics of the Finerenone Trial in Slowing Kidney Disease Progression in Diabetic Patients”, IMCHP, vol. 1, no. 2, pp. 32–43, Jan. 2025, doi: 10.69725/imchp.v1i2.212.